Mjoen (1982) [19]
|
Critical
|
Critical risk of bias in classification of interventions domain: ototoxic medications grouped as one variable (i.e., furosemide not identified as a single risk factor).
|
Salamy (1989) [20]
|
Moderate
|
Confounding well-accounted for by assessing “neonatal status” based on duration of hospitalization, days of assisted ventilation, radiography and lab results, etc.
|
Brown (1991) [21]
|
Serious
|
Serious risk of bias in confounding domain: Selection of variables included in the multivariate analyses based solely on results of univariate analyses and did not adequately account for severity of illness in each group.
|
Borradori (1997) [22]
|
Moderate
|
Confounding well-accounted for by the creation of two control groups based on BW/GA and perinatal complications related to risk of ototoxicity.
|
Ertl (2001) [23]
|
Serious
|
Serious risk of bias in confounding domain: infants not matched on severity of illness or co-morbidities associated with hearing loss.
|
Rais-Bahrami (2004) [24]
|
Serious
|
Serious risk of bias in confounding domain: no adjustment for perinatal factors related to hearing loss.
|
Xoinis (2007) [25]
|
Serious
|
Serious risk of bias in confounding domain: infants not matched on severity of illness or co-morbidities associated with hearing loss.
|
Coenraad (2011) [26]
|
Serious
|
Serious risk of bias in confounding domain: infants not matched on severity of illness or co-morbidities associated with hearing loss.
|
Martinez-Cruz (2012) [27]
|
Serious
|
Serious risk of bias in confounding domain: infants not matched on severity of illness or co-morbidities associated with hearing loss.
|
Rastogi (2013) [28]
|
Moderate
|
Confounding well-accounted for in multivariate analyses, which adjusted for GA, BW, and other known perinatal risk factors for hearing loss.
|
Wang (2017) [29]
|
Critical
|
Critical risk of bias in classification of interventions domain: ototoxic medications grouped as one variable (i.e., furosemide not identified as a single risk factor).
|